Status:
COMPLETED
Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
Lead Sponsor:
Nationwide Children's Hospital
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Muscular Dystrophy Association
Conditions:
Limb-Girdle Muscular Dystrophy
Eligibility:
All Genders
Brief Summary
The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for futur...
Eligibility Criteria
Inclusion
- any subject with clinical diagnosis of LGMD
- must visit Columbus Children's Hospital for 2-day study visit
- muscle biopsy tissue must be available; either from previous biopsy, affected relative, or willing to have biopsy at Columbus Children's
Exclusion
- diagnosis of a neuromuscular disorder other than LGMD
- unable to provide muscle tissue from previous or current biopsy
- incapable of giving consent and not having a legal guardian willing or able to do so
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2018
Estimated Enrollment :
277 Patients enrolled
Trial Details
Trial ID
NCT00457912
Start Date
June 1 2005
End Date
January 1 2018
Last Update
January 25 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205